ArticleACS medicinal chemistry letters2015

Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.

Honghe Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.